“Novel Sustained-Release Nateglinide Microspheres: In Vitro Evaluation for Improved Antidiabetic Therapy”, JOC, vol. 23, no. 1, pp. 860–870, Dec. 2024, doi: 10.64149/J.Carcinog.24.6s.232-242.